SCHEMBL4757032

SCHEMBL4757032

O=C(O)c1cc(Cl)cc(N2CCOCC2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.62
TPMT P51580 1/20 0.52
POLB P06746 1/20 0.49
MAPT P10636 5/20 0.48
PIK3CA P42336 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ACLY P53396 1/20 0.47
AKR1C3 P42330 2/20 0.46
HCAR1 Q9BXC0 1/20 0.46
PRKDC P78527 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
GSK3B P49841 1/20 0.44
LMNA P02545 3/20 0.43
PIK3CD O00329 1/20 0.43
PIK3CB P42338 1/20 0.43
PIK3CG P48736 1/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27893364 0.90 KMO (0.70) KMOPOLBMAPTPIK3CASMN1; SMN2
SCHEMBL27472161 0.85 MAP2 (0.49) KMOMAPTSMN1; SMN2AKR1C3PRKDC
SCHEMBL2724092 0.82 KMO (0.60) KMOPOLBMAPTPIK3CASMN1; SMN2
SCHEMBL593762 0.82 KMO (0.60) KMOPOLBMAPTPIK3CASMN1; SMN2
SCHEMBL24236054 0.82 PRKDC (0.54) MAPTSMN1; SMN2AKR1C3PRKDCALDH1A1
SCHEMBL1252295 0.82 CHRM2 (0.57) MAPTSMN1; SMN2ACLYAKR1C3PRKDC
SCHEMBL4758239 0.81 MAPK14 (0.47) KMOMAPTSMN1; SMN2AKR1C3ALDH1A1
SCHEMBL545939 0.80 TPMT (0.52) TPMTPOLBSMN1; SMN2HCAR1ALDH1A1
SCHEMBL21712061 0.80 KMO (0.57) KMOPOLBMAPTPIK3CASMN1; SMN2
SCHEMBL15122791 0.78 KMO (0.56) KMOPOLBMAPTPIK3CASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed